Skip to content

Research on Rapid and Precise Identification Methods of Key Genes for Carbapenem Resistance and Their Clinical Application

Research on Rapid and Precise Identification Methods of Key Genes for Carbapenem Resistance and Their Clinical Application

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128796
Enrollment
Unknown
Registered
2026-07-26
Start date
2024-10-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carbapenem resistant gram-negative bacteria infection

Interventions

Gold Standard:The drug-resistant genotypes of clinical CRO were obtained by second-generation gene sequencing and drug susceptibility tests
Index test:1. CRISPR/Cas9-LFS rapid detection method of single double resistance gene 2, multi-drug resistance gene CRISPR/Cas9-mLFS rapid detection method

Sponsors

Tongling People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Carbapenem resistant gram-negative bacteria infection specimen;

Exclusion criteria

Exclusion criteria: 1.IMultiple strains of infection from the same patient in different parts and at different times;

Design outcomes

Primary

MeasureTime frame
Sensitivity;specificity;accuracy;

Secondary

MeasureTime frame
false positive rate;false negative rate;

Countries

China

Contacts

Public ContactRuibao Jiao

Tongling People's Hospital

ahtljiao@139.com+86 562 2827195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026